Peptide Research Literature Index
A structured, dated index of the research-peptide landscape

Can FDA ban a person from the drug business?

Reference page · published 2026-11-16

Yes. It is called debarment, and FDA keeps two separate public lists of the people it has banned.

Almost everyone who has heard of debarment has heard of the first list. It holds 152 people, and 146 of them are banned permanently. What it bans them from is narrow: working, in any role, for a company that holds or has applied for an approved drug. If you were never in that business, a permanent ban from it costs you nothing.

The second list is the one that matters to anyone selling research compounds on a website. It bans people from importing drugs into the United States, it holds 63 people, nobody on it is banned permanently — and two of the twenty-five criminal defendants in our own case records are on it. Both for five years. Both because, as FDA put it, the facts behind the conviction were conduct relating to the importation into the United States of a drug or controlled substance.

This page covers what debarment is in the statute's own words, what each list actually contains, how a person ends up on one without ever attending a hearing, how long the process takes, and — the part that reads differently from the headline — the several ways a search of these lists can mislead you.

What debarment is

Debarment is not a prison sentence and not a fine. It is an administrative order that forbids a person from doing certain things. FDA's own description is brief:

FDA debarment is a legal action that prohibits individuals and entities from participating in certain activities related to FDA-regulated industries

The authority is section 306 of the Federal Food, Drug, and Cosmetic Act, which sits in the United States Code at 21 U.S.C. 335a, titled Debarment, temporary denial of approval, and suspension.

One warning before you go looking for it. Both of FDA's list pages cite the statute as 21 U.S.C. 335(a) or (b), dropping the letter from the section number. If you follow that, you land on section 335, which is about something else entirely. The debarment section is 335a — and the footer of the same FDA pages gets it right, saying the list is compiled in accordance with 21 U.S.C. 335a(e) from notices published in the FEDERAL REGISTER. Two citations on one page, one of them wrong. Use the footer.

The statute was written in 1992 for a scandal that had nothing to do with websites. Congress said so in the law itself:

there is substantial evidence that significant corruption occurred in the Food and Drug Administration's process of approving drugs under abbreviated drug applications

That is the generic-drug approval scandal of the late 1980s. The remedy Congress built was aimed squarely at it: bar the people who had corrupted the approval process from working for companies that use the approval process. Thirty-four years later the same statute is being used against people who ran storefronts, and it reaches them through a clause that was added much later.

Mandatory and permissive: two different machines

Section 335a has two engines, and which one is used decides almost everything about the outcome.

Mandatory debarment — subsection (a). If FDA finds that an individual was convicted of a federal felony for conduct relating to approving a drug, or otherwise relating to the regulation of any drug product under this chapter, then the Secretary shall debar such individual from providing services in any capacity to a person that has an approved or pending drug product application. The word is shall. There is no discretion about whether. And the length is fixed: The debarment of an individual under subsection (a)(2) shall be permanent.

Permissive debarment — subsection (b). Here FDA may act, it weighs a list of factors, and the term is capped: The period of debarment of any person under paragraph (2) or (3) of subsection (b) shall not be more than 5 years. The next sentence is the reason some entries read ten or twenty years: The Secretary may determine whether debarment periods shall run concurrently or consecutively in the case of a person debarred for multiple offenses.

Buried in the permissive half is the clause that catches internet sellers. A person is subject to import debarment if the person has been convicted of a felony for conduct relating to the importation into the United States of any drug or controlled substance.

Read those two engines side by side and the shape of the whole system appears. A conviction for selling unapproved drugs online is, on its face, a felony otherwise relating to the regulation of any drug product under this chapter — which triggers the mandatory engine and a permanent ban. But the thing that ban forbids is working for a company with an approved drug application. For someone who ran a website and bought powder abroad, that is a ban on a career they never had. The sanction with actual teeth is the discretionary, time-limited, import one.

What the two lists actually contain

Both lists were read in full on November 16, 2026. The counts below are of the rows on those pages, parsed and then checked by hand.

Drug Product Applications listDrug Imports list
Firms listedNone as of this dateNone as of this date.
People listed15263
Permanent1460
Time-limited663
Statutory basismostly mandatory, section 306(a)all permissive, section 306(b)
Earliest effective dateMarch 8, 1993November 29, 2019
Latest effective dateSeptember 25, 2026September 25, 2026

Start with what is not there. Neither list names a single company. Both firm tables read None as of this date. Every one of the 215 entries across the two lists is a named human being. If your mental model of enforcement is that the company gets punished, these two documents are the clearest evidence against it anywhere in the public record.

The notation columns are worth decoding, because FDA publishes the legend and almost nobody reads it. A caret means Mandatory Debarment (Sec. 306(a)). A percent sign means Permissive Debarment (Sec. 306(b)). An asterisk means Hearing requested and denied. A hash means Acquiesced to Debarment. On the imports list there is one more: a lower-case p means Debarment based on a pattern of importing or offering for import.

Run the legend across the rows and three things fall out.

All 146 permanent entries are mandatory ones. Every single permanent debarment on the applications list carries the caret. Not one is a discretionary decision. They are permanent because the statute left FDA no choice.

Twenty-one people asked for a hearing and were refused, and three agreed to be debarred. The statute allows the second of those explicitly: a person may notify FDA that they accept debarment, and it begins on notification — which can happen upon execution of an agreement with the United States to plead guilty, before any sentence.

Six of the 63 import debarments rest on a pattern, not a conviction. That is the lower-case p. The statute allows debarment for importing in a quantity that is not personal use at all — it defines the pattern as an amount, frequency, or dosage that is inconsistent with personal or household use by the importer. No conviction is required for that route. Six people are on the list through it.

The two lists barely overlap. Exactly one person appears on both: a single Federal Register order, 91 FR 55886, produced a permanent entry on the applications list and a twenty-year entry on the imports list on the same day. Everybody else is on one list or the other, which is the clearest proof that these are two different sanctions and not one sanction published twice.

Two people in our own case records are on the import list

This index keeps dossiers on criminal cases against sellers of research compounds and research chemicals. To test whether debarment actually reaches this corner of the market, we took a defined population: every natural person named as a criminal defendant in a case dossier in our archive — 25 people, drawn from 16 of the 17 case dossiers — and searched both FDA lists for each surname, then compared given names before calling any match a person. The seventeenth dossier contributes nobody: the defendant convicted in it is a company, not a person.

Result: two of twenty-five. Neither is on the applications list. Both are on the imports list. Both got five years.

The first order is dated February 12, 2026. FDA is debarring Jeremy Spencer Brown for a period of 5 years from importing or offering for import any drug into the United States, and states the basis plainly:

FDA bases this order on a finding that Mr. Brown was convicted of one felony count under Federal law for introduction of unapproved drugs into interstate commerce with intent to defraud or mislead.

The order's own account of the business will be familiar to anyone who has read the warning letter that preceded it: Mr. Brown was the owner and operator of the company Warrior Labz SARMs and its multiple websites. He obtained the bulk of the drugs he sold through his websites from China and nor did he use a lab or other method to verify the contents of the drugs he received from China — while, the order says, his own websites advertised ingredients of the highest quality and American manufacturing practices, and the labels falsely stated that the drugs were made in the United States.

The second order is dated January 23, 2026, and it is a different case in a different state. FDA is debarring Tyler Jordan Hall for a period of 5 years from importing or offering for import any drug into the United States. The order describes a business that imported, bottled and labeled, and a seller who was never a pharmacist, he did not employ a licensed pharmacist at Rat's Army, and he never registered his business with the FDA as a pharmaceutical manufacturing facility. On the shipping side:

In order to avoid seizure by United States Customs and Border Protection officers of the materials that Mr. Hall shipped internationally, Mr. Hall falsely claimed that they were supplements or vitamins.

What the orders say about research-use wording

In both orders the research-use disclaimer is not a defense. It is part of the offense. This is the single most quotable thing in either document, and it comes from a published Federal Register order, not from a press release.

Of the first seller, the order says he included disclaimers that he knew were false and misleading — and names them: the drugs were said to be for research purposes only and not for human consumption.

Of the second, the order is blunter still:

Mr. Hall attempted to conceal the nature of his products by falsely portraying them as research chemicals and not for human consumption, despite knowing and intending that the products were for ingestion by humans

Note what is doing the work in both sentences. It is not the words on the label. It is the gap between the words and what the seller knew and intended. This is the same reasoning that runs through the warning letters, and we cover it at length in why a research-use disclaimer is not a defense and whether research framing is itself a drug claim. The debarment orders are simply where that reasoning turns into a second, separate penalty after the criminal case has already closed.

How a person gets debarred without a hearing

Both of the people above had the right to a hearing and neither used it. The mechanism is a letter and a clock, and it is described identically in both orders.

FDA sends notice of the proposed debarment. The person has thirty days from receipt to request a hearing. If nothing arrives, that is the end of it:

Mr. Brown's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

The second order says the same of the second seller, with its own date: As of September 2, 2025 (30 days after receipt of the notice), Mr. Hall had not responded.

So the practical answer to "can I fight this" is yes, and the practical answer to "did they" is no. Of the 152 people on the applications list, 21 carry the notation for a hearing requested and denied, which means asking is not futile — it is simply rarer than not asking.

How long it takes after the conviction

Longer than people expect, and this matters for reading the lists.

The first seller was convicted on February 3, 2025, when the court accepted his guilty plea. The debarment order took effect February 12, 2026 — 374 days later. The second was convicted on May 15, 2025 and debarred effective January 23, 2026, 253 days later.

Start the clock at the moment the hearing right lapsed instead, and the gaps are 267 and 143 days.

Two cases are not a distribution, and this page does not claim they are. But they do establish that the lag runs to roughly eight to twelve months in observed practice, which is the single most important fact for interpreting an absence. If a conviction landed less than a year ago, the person not being on a list tells you almost nothing yet.

There is also an outer limit in the statute, running the other way. Mandatory debarment shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action. If FDA does not start within five years of the conviction, that route closes.

Does permanent mean permanent?

Not always, and FDA publishes the proof itself.

Alongside the two current lists there is a third page: the expired list, for people whose debarment pursuant to sections 306(a) or (b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 335(a) or (b)) has either expired or has been terminated. It holds 62 named people — and 10 of them have a term recorded as permanent.

The statute explains how. A conviction that is reversed ends the debarment outright. And there is a special route for cooperation: an individual who has provided substantial assistance in the investigations or prosecutions of offenses can have a permanent debarment cut to less than permanent but to no less than 1 year — though the statute attaches a condition to that reduction, which applies whichever best serves the interest of justice and protects the integrity of the drug approval process. It is a possibility, not an entitlement.

A person can also appeal. Anyone subject to an adverse debarment decision may obtain a review of such decision by the United States Court of Appeals within sixty days.

Who else a debarment reaches

A debarment order is not only about the person named in it. Both import orders close with the same sentence, and it is the part that reaches other people:

the importing or offering for import into the United States of any drug by, with the assistance of, or at the direction of Mr. Brown is a prohibited act.

Read that carefully. It is not merely that he may not import. It is that importing at his direction is itself a prohibited act — so a supplier, a shipper or a partner who keeps the goods moving on his instructions is the one committing it.

On the applications side the equivalent teeth are financial. The twenty-year order cited above states that Any person with an approved or pending drug product application, who knowingly uses the services of a debarred person in any capacity during his period of debarment, will be subject to civil money penalties, and that the debarred person faces them too.

And the whole scheme is enforced by a signature. Every drug application must contain a certification that the applicant did not and will not use in any capacity the services of any person debarred under subsection (a) or (b), in connection with such application. That is why the lists exist in a searchable form at all: industry is required to check them.

One last definition worth knowing, because it closes a door people assume is open. For debarment purposes a person counts as convicted even where the court never entered a conviction — including when the person has entered into participation in a first offender, deferred adjudication, or other similar arrangement or program where judgment of conviction has been withheld. A deal that keeps a conviction off the record does not keep it out of this statute.

What does the evidence not show?

Eight limits, and most of them cut against the headline above.

  1. Two of twenty-five is not a rate for the industry. Our 25 people are the criminal defendants we have documented, chosen because their cases were findable and relevant. That is not a sample of anything. It supports the claim "this sanction reaches this corner of the market" and supports no claim about how often.
  2. Some of the twenty-five cannot be debarred on this ground at all, which means the denominator is wrong in kind and not only in size. Debarment under the import provision needs a conviction. At least three of our 25 do not have one. As our records stood when this page was written, two of them faced charges that were still only allegations, with no plea and no verdict: one had a jury trial set for December 2026, and the other had not yet been arraigned. A third case was not a criminal prosecution at all — it was resolved by a civil consent decree. Several more people have been convicted but not yet sentenced. So a rate calculated over all 25 divides by people this sanction could not have reached yet even in principle.
  3. And the ones who have been convicted recently have not had time to appear. The only two conviction-to-debarment intervals we can actually observe are 253 and 374 days. Much of our population was convicted inside that window. A low count is substantially an artefact of our own archive being recent, not evidence that anyone escaped.
  4. A surname search produces false hits, and one nearly fooled us. The applications list contains a Brown, debarred permanently in 2017. He is not the seller discussed above; his given names are different and his debarment predates that case by nine years. Our 25 surnames produced three hits across the two lists and one of those three was a different person. Independently of our archive, the two FDA lists collide with each other on six surnames that belong to different people. A surname match is never an identification — read the given name, then read the Federal Register order.
  5. The lists are snapshots of who is currently debarred. Absence is not evidence a person was never debarred, because expired and terminated debarments move to a different page, and that page holds 62 more people.
  6. Our count of Federal Register orders is a floor, not a census. Searching the Federal Register for FDA documents whose titles contain "Final Debarment Order" returns 183 documents, the oldest dated January 6, 1994. But the lists themselves contain an effective date of March 8, 1993, earlier than any document that search finds — because older orders were titled differently. The 183 is what one phrase catches, and we report it as such.
  7. Import debarment does not stop domestic selling. It bars importing and offering for import. It is not a license revocation, not a shutdown order, and not a bar on being in business. For a comparison with sanctions that do close a company, see whether a court can shut a company down.
  8. We did not read the underlying court records for these two orders. Everything attributed to the convictions here is FDA's account of them in a published order, which is a summary written by one party for an administrative purpose. It is a primary source for what FDA found, not a transcript of what happened.

One more, about the method itself, and we are printing it in full because it went wrong twice in the same place.

Our first version of this check built its population from filenames — one surname per dossier. That undercounted, because one dossier covers more than one case, and the extra defendant turned out to be one of the two people on the list. We caught it, corrected the count to 23, and wrote the rule down.

The corrected count was still wrong. Re-deriving the population a second time, from the case captions in the documents instead of from a reading of each file, found three more convicted people in that same dossier — it holds four cases, not two — and one person who should never have been in the population at all, because she is a defendant in a different dossier that the rule does not cover. Twenty-three was really twenty-five. The numerator did not move, so the finding above survives, but the rate we would have published was calculated on the wrong base.

The lesson is not that the first count was careless. It was careful, and the rule was written down. The lesson is that the rule was applied by reading each file once, and a file that surprises you once can surprise you again in exactly the same way. A count is only as trustworthy as the second, independent way you derived it — so the second derivation, and the checks it runs on itself, are part of this index's method from here on.

How to check a name yourself

All three pages are public, free, and require no account.

  1. Check both current lists. They are separate pages with separate contents, and the one most people find first is the one least likely to hold an online seller.
  2. Then check the expired list, which is where terminated and lapsed debarments go.
  3. Match on the full name, not the surname. One in three of our own surname hits turned out to be a different person.
  4. Open the Federal Register order the row links to. The order states the conviction, the court, the dates and the statutory basis. The list row states none of that.
  5. If a name is absent and the conviction is less than a year old, write down "too early to tell." Do not write down "not debarred."

Debarment is one of several federal records about a person or a company, and each answers a different question. A warning letter is what the agency decided to allege. A felony misbranding charge is what a prosecutor decided to file. A sentence is what a judge imposed, and most of these cases end in probation. Debarment is what the agency did afterwards, on its own authority, once the court was finished. If you are working through a supplier in order, the vendor compliance questions and the record lookup put this one in sequence with the rest.

Nothing on this page is an accusation against any company. It is a note on how to read a particular kind of federal record, including the ways it can be read wrongly.

Sources

  1. United States Code — 21 U.S.C. 335a, Debarment, temporary denial of approval, and suspension (FDCA section 306), 2023 edition, retrieved from the Government Publishing Office on November 16, 2026. govinfo.gov/…/USCODE-2023-title21-…-sec335a.htm — the source of every quotation attributed to the statute, including the 1992 congressional findings printed as a note to the section.
  2. US FDA — FDA Debarment List (Drug Product Applications), read November 16, 2026. fda.gov/…/fda-debarment-list-drug-product-applications — 152 named people, 146 permanent, no firms. All counts on this page were taken by parsing the page's own tables and then checking the rows by hand.
  3. US FDA — FDA Debarment List (Drug Imports), read November 16, 2026. fda.gov/…/fda-debarment-list-drug-imports — 63 named people, none permanent, no firms. Term values as published: 47 entries of five years, 13 of ten years, two of fifteen, one of twenty.
  4. US FDA — FDA Expired Debarment List (Drug Product Applications), read November 16, 2026. fda.gov/…/fda-expired-debarment-list-drug-product-applications — 62 named people, of whom ten carry a term recorded as permanent.
  5. Federal Register — Jeremy Spencer Brown: Final Debarment Order, 91 FR 6643, published February 12, 2026, Docket No. FDA-2025-N-0435. federalregister.gov/…/jeremy-spencer-brown-final-debarment-order
  6. Federal Register — Tyler Jordan Hall: Final Debarment Order, 91 FR 2940, published January 23, 2026. federalregister.gov/…/tyler-jordan-hall-final-debarment-order
  7. Federal Register — Rahim Shafa; Denial of Hearing; Final Debarment Order, 91 FR 55886, published August 31, 2026 — the one order that placed a person on both lists at once, and the source of the civil money penalty sentences quoted above. federalregister.gov/…/rahim-shafa-denial-of-hearing-final-debarment-order
  8. Federal Register API — FDA documents whose title contains the phrase "Final Debarment Order", queried November 16, 2026: 183 documents, January 6, 1994 to September 25, 2026. Reported on this page as a floor and not a total, for the reason given above. federalregister.gov/api/v1/documents.json
  9. Note on the cross-check. The population was the 25 natural persons named as criminal defendants in this index's enforcement archive, drawn from 16 of its 17 case dossiers; the seventeenth records the conviction of a company, not of any person. The population was derived twice, by two different routes, and the two did not agree the first time — see the method note above. Matching was word-bounded on the surname column of each list, and every surname hit was then compared on given and middle name before being called the same person or a collision. The matcher's controls — a name known to be on each list, a nonsense name, a substring that must not match, a same-surname-different-given-name pair, and a same-given-name-different-middle-name pair — were run and passed before any count was taken.

Further reading

  1. The Warrior Labz warning letter — the document the first debarment order describes him receiving and continuing past.
  2. Why a research-use disclaimer is not a defense — the reasoning both orders apply to the wording on the labels.
  3. What the 70 months was for — the criminal half of the picture, where the sentences come from.
  4. Can a court shut a company down? — the sanction debarment is often confused with.
  5. Convicted for what an employee did — the page that raises debarment as a consequence of a misdemeanour and sends you here.
  6. The FDA import alert red list — a different import-side record, about products instead of people.
  7. How to search a court filing — for reading the convictions behind these orders yourself.
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.